GlassScriptPhysician profile
Tennyson W Lee
NPI 1518964980
$2,036.81
in general payments reported to CMS, 2019-2025
15 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $79.52 · 2021: $601 · 2022: $707 · 2023: $212 · 2024: $107 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,492.46 | 2019-2025 | Avista Mri, Wavewriter Alpha Prime 16, Fixate |
| Si-Bone, INC. | $143.33 | 2019-2023 | |
| Abbott Laboratories | $128.37 | 2022-2023 | Proclaim |
| Medtronic, INC. | $62.30 | 2022-2024 | Intellis Adaptivestim |
| Pacira Therapeutics, INC. | $33.04 | 2019-2020 | |
| Fidia Pharma USA INC. | $32.79 | 2025 | Hymovis |
| Amarin Pharma, INC. | $22.85 | 2021 | |
| Avanos Medical | $20.68 | 2024 | Generator |
| Medtronic USA, INC. | $16.39 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $15.95 | 2025 | |
| Radius Health, INC. | $15.38 | 2020 | |
| Abbvie INC. | $13.88 | 2022 | |
| Relievant Medsystems, INC. | $13.76 | 2021 | |
| Zyla Life Sciences, INC. | $12.99 | 2020 | |
| Ferring Pharmaceuticals INC. | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tennyson Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.